Left Archives - WinWay Health Blog

health remedies

Left out of Warp Speed, Novavax scores $60M defense contract for...

Winway Health Desk - June 5, 2020

Novavax wasn’t included in the U.S. government’s group of COVID-19 vaccine finalists for Operation Warp Speed, but only days after news of those picks broke,...

FDA Approves Ponvory (ponesimod) for the Treatment of Adults with Relapsing Multiple Sclerosis

Winway Health Desk - March 20, 2021

Novartis study: Nurses and MS patients give thumbs-up to Kesimpta for ease-of-use

Winway Health Desk - March 3, 2021

Sen. Schumer curiously links Shingrix shortage to shutdown, but Glaxo says there’s no connection

Winway Health Desk - January 16, 2019

AI-biotech Terray emerges with $60M and a solution for data problems in drug R&D

Winway Health Desk - February 15, 2022

Tag: Left

Left out of Warp Speed, Novavax scores $60M defense contract for...

EDITOR PICKS

FDA Approves Ponvory (ponesimod) for the Treatment of Adults with Relapsing Multiple Sclerosis

Novartis study: Nurses and MS patients give thumbs-up to Kesimpta for ease-of-use

Sen. Schumer curiously links Shingrix shortage to shutdown, but Glaxo says there’s no connection

AI-biotech Terray emerges with $60M and a solution for data problems in drug R&D

EVEN MORE NEWS

Demystifying Coding Compliance: 3 Key Strategies for Navigating the Regulatory Waters...

Experts Aren’t Surprised About Optum Closing Its Virtual Care Business

Labcorp Makes Another Acquisition, Plucking Invitae Assets From Bankruptcy Auction

POPULAR CATEGORY